Regulate the Price of All Drugs Act

This bill creates a new federal commission to set maximum prices for all approved prescription drugs, including insulin and vaccines, starting in 2027. The commission would determine these "fair prices" by considering manufacturing costs, therapeutic benefits, and prices in other countries, while the Health and Human Services Secretary would publish the final prices that drug makers must charge. Manufacturers that sell drugs above these set prices would face significant fines, and the bill grants the government the authority to bypass patent protections to increase drug production if domestic supply is insufficient.